ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary ...

there is no increased risk in comparison to control arms of intracranial bleeding with the addition of a GP IIb/IIIa inhibitor. Few data, however, are available for higher risk patient ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

Caution should be exercised when concomitant use of XIFAXAN and P-glycoprotein (P-gp) and/or OATPs inhibitors is needed. Concomitant administration of cyclosporine, an inhibitor of P-gp and OATPs ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

The CCR5 proteoliposomes bind the HIV-1 gp120 envelope glycoprotein and conformation ... particularly in establishing screens for inhibitors. When solubilized using specific detergent and salt ...

Corpus callosum levels of Oligodendrocyte myelin glycoprotein (OMgp), Chondroitin sulfate proteoglycans ... NEP1-40 peptide administration mitigated expression of axonal outgrowth inhibitor OMgp and ...

Objective Dipeptidyl peptidase-4 (DPP4), also known as CD26, is a transmembrane glycoprotein that has a costimulatory function in the immune response. DPP4 inhibitors (DPP4i) are oral glucose-lowering ...

Breakthrough Therapy designation Clesrovimab (Merck) Fusion glycoprotein neutralizing monoclonal antibody ... Combination of a non-nucleoside reverse transcriptase inhibitor and a nucleoside reverse ...

Glycoprotein non-metastatic melanoma protein B (GPNMB ... in vitro functional assays, and inhibitor treatments, in vivo animal studies, real-time quantitative PCR (qRT-PCR), next-generation ...